Aurobindo Pharma Q2 Net up 5.7% at Rs 235 crore
Aurobindo Pharma today said its consolidated net profit rose 5.7 per cent to Rs 235 crore for the second quarter ended September 30, 2013.
By PTI |
NEW DELHI: Aurobindo Pharma today said its consolidated net profit rose 5.7 per cent to Rs 235 crore for the second quarter ended September 30, 2013.
The Hyderabad-based firm posted a profit after tax of Rs 222.4 crore during July-September last year.
The company's total income from operations increased by 27.6 per cent to Rs 1,913.9 crore in the second quarter (Q2) of this fiscal compared to Rs 1,500.4 crore in the same period last fiscal, Aurobindo Pharma said in a statement.
"The integrated business in generic formulations is auguring well to drive the operating performance of the company. We are also investing in specific new, differentiated products offerings such as Oncology, Hormones, Peptides and OTC business which we believe will complement our business in the coming years," Aurobindo Pharma Ltd Managing Director N Govindarajan said.
Shares of Aurobindo Pharma closed at Rs 238.35 apiece, down 1.71 per cent on the BSE.
The Hyderabad-based firm posted a profit after tax of Rs 222.4 crore during July-September last year.
The company's total income from operations increased by 27.6 per cent to Rs 1,913.9 crore in the second quarter (Q2) of this fiscal compared to Rs 1,500.4 crore in the same period last fiscal, Aurobindo Pharma said in a statement.
"The integrated business in generic formulations is auguring well to drive the operating performance of the company. We are also investing in specific new, differentiated products offerings such as Oncology, Hormones, Peptides and OTC business which we believe will complement our business in the coming years," Aurobindo Pharma Ltd Managing Director N Govindarajan said.
Shares of Aurobindo Pharma closed at Rs 238.35 apiece, down 1.71 per cent on the BSE.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
